Cameron Curley

发表

Use of brentuximab vedotin as salvage therapy pre‐allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho‐proliferative disorders: a single centre experience

J. Butler, K. Morris, G. Kennedy, 2017, Internal medicine journal.

High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation

S. Durrant, N. Weber, G. Kennedy, 2022, Bone Marrow Transplantation.

A prospective phase II randomized study of deferasirox to prevent iatrogenic iron overload in patients undertaking induction/consolidation chemotherapy for acute myeloid leukaemia

J. Butler, S. Durrant, K. Morris, 2013, British journal of haematology.

Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia

C. Olsen, Siok-Keen Tey, A. Scott, 2023, Bone marrow transplantation.

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.

N. Cloonan, G. Thomas, G. Boyle, 2014, The Lancet. Oncology.

Mismatched unrelated donor allogeneic stem cell transplant for high risk haematological malignancy: A single centre experience

G. Hill, J. Butler, S. Durrant, 2017, Blood Cancer Journal.

A Phase 3 Double-Blind Study of the Addition of Tocilizumab versus Placebo to Cyclosporin/Methotrexate GvHD Prophylaxis.

S. Paul, G. Hill, K. Gartlan, 2021, Blood.

Effect of plasmapheresis on ATG (Thymoglobulin) clearance prior to adoptive T cell transfer

G. Hill, J. Roberts, M. Nakagaki, 2019, Bone Marrow Transplantation.

A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation

M. Barras, M. Nakagaki, G. Kennedy, 2017, Supportive Care in Cancer.

Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD

J. P. Martins, G. Hill, S. Durrant, 2016, Bone Marrow Transplantation.

Alemtuzumab as salvage therapy for steroid and ATG/etanercept-refractory acute GVHD

S. Durrant, M. Nakagaki, G. Kennedy, 2011, Bone Marrow Transplantation.

Is extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation associated with improved survival?

S. Durrant, G. Kennedy, C. Curley, 2013, Asia-Pacific journal of clinical oncology.

Phase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T Cells

L. Coin, M. Brown, T. Gargett, 2019, Clinical Cancer Research.

The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR

G. Kennedy, A. Spencer, T. Perera, 2022, Bone Marrow Transplantation.